















1342Chances of Finding an HLA-Matched Sibling: The Saudi
Experience
Dunia M. Jawdat,1 Salwa Al Saleh,2 Paul Sutton,2 Hanan Al Anazi,2 Abdullah Shubaili,2
Hani Tamim,1 Ali H. Hajeer2,3Hematopoietic cell transplantation (HCT) remains the fundamental procedure to treat many diseases. Its
success depends greatly on the degree of HLA matching between donor and recipient. Although the number
of successful HCT procedures carried out worldwide increases every year, many patients remain unable to
receive this treatment because of the difficulty of finding an HLA-matching donor. In our center, we identified
the HLA types for all HCT candidates and their siblings in an attempt to determine the chance of finding a full
HLA-matching sibling. Overall, 60% of patients had a chance of finding an HLA-matching sibling. The chance of
finding a matching sibling was 43% in patients aged birth to 5 years, compared with 68% in those aged 201
years. In our Saudi population, patients in need of HCT have a greater chance of finding an HLA-matching
sibling than is reported in most Western countries. This is mainly because of the larger number of siblings
in most Saudi families. Younger children requiring HCT have a lesser chance of finding an HLA-matching sib-
ling. Our data demonstrate that even in a country with relatively large families, it is still essential to consider
alternative donor strategies, such as adult unrelated donors, unrelated umbilical cord blood units, and hap-
loidentical donors.
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Hematopoietic cell transplantation (HCT) is giving
patients with such life-threatening diseases as leukemia
[1], lymphoma [2], aplastic anemia (AA) [3], multiple
myeloma (MM) [4], and immune deficiency disorders
a good chance for cure. The number of patients under-
going HCT is increasing every year; however, a large
percentage of those in need of HCT are unable to
undergo the procedure because of the lack of an
HLA-matching donor. If an HLA-identical sibling is
not available, then an unrelated donor must be consid-
ered [5]. Choosing an unrelated donor is very critical;1King Abdulla International Medical Research Centre
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of donor and recipient is crucial. The better the HLA
match between donor and recipient, the better the out-
come. In some cases, HCT with a partially HLA-mis-
matched donor has been successful; however, some
diseases are critical and require a full identical HLA
match between donor and recipient.
Theoretically, in each family there is a 25% (1 in 4)
chance of inheriting the same HLA haplotype, a 25%
chance of inheriting no matching HLA haplotype
(zero sharing), and a 50%chance of inheriting 1match-
ing HLA haplotype between siblings. In Saudi Arabia,
families tend to be large, with an average of 5.03 chil-
dren per family [6]. Saudi Arabia also has a high rate of
consanguinity. A study of Saudi families found that
57.7% of screened families were consanguineous,
with the most being first-cousin marriages [7].
The aim of the present study was to investigate the
chance of finding an HLA-matching sibling for Saudi
patients requiring HCT.MATERIALS AND METHODS
This study was conducted at the HLA Laboratory,
King Abdul Aziz Medical City, Riyadh. All patients’
files for HCT were retrospectively screened for HLA
class I and class II typing of patients and their potential
Table 1. Number of Patients and Sex Distribution per Age
Category
Age Group, Years Patients, n (%) Female Sex, n (%)
0-5 53 (12.6) 21 (39.6)
6-10 78 (18.6) 36 (46.2)
11-20 105 (24.9) 43 (41.0)
>20 185 (43.9) 66 (35.7)
Total 421 166 (39.4)
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and percentages of patients with 1 or more full HLA-
matching siblings in our center were analyzed.
Data were entered in a Microsoft Excel sheet, and
the SPSS V16.0 statistical software package (SPSS Inc,
Chicago, IL) was used for statistical analysis. Data
were summarized by mean and standard deviation
(6) for continuous variables and by number and per-
centage for categorical variables. The actual probabil-
ity of finding a matching sibling was found by
calculating the percentage of patients who had at least
1 matching sibling. The predicted probability of find-
ing a matching sibling was calculated as [1 - (0.75)x],
where x is the number of siblings. A multivariate logis-
tic regressionmodel was used to identify the predictors
of finding a matching donor, with age, number of
siblings, and sex included in the model.RESULTS
We examined the HLA class I and class II types of
all patients requiring HCT and their potential donors
(siblings). We ended up with a total of 421 patients
whose siblings were tested for both HLA class I and
class II. Table 1 reports the age and sex distributions
in the group.
Table 2 shows the average number of patients’
HLA-tested siblings, along with the average number
of their HLA-matching siblings. There was a trend
toward an increasing number of siblings with increasing
patient age. Overall, the average number ofHLA-tested
siblings for eachpatientwas 4.0, and the averagenumber
of fully HLA-matching siblings was 0.9, suggesting that
each patient has approximately 1 matching donor. We
divided our patients into 4 age groups: group 1 (aged









0-5 2.7 ± 1.4 0.6 ± 0.8
6-10 3.6 ± 2.2 1.0 ± 1.1
11-20 4.1 ± 2.2 0.8 ± 1.0
>20 4.6 ± 2.2 1.0 ± 0.9
All 4.0 ± 2.2 0.9 ± 1.011-20 years), and group 4 (aged. 20 years). We found
anaverageof 2.7 siblings ingroup1,3.6 siblings in group
2, 4.1 siblings in group 3, and 4.6 siblings in group 4, and
an average of 0.6 full HLA-matching siblings for group
1, 1.0 for group 2, 0.8 for group 3, and 1.0 for group 4.
These findings indicate a greater chance of finding
a full HLA-matching sibling at an age. 20.
Table 3 presents the number of matching siblings,
ranging from 0-5, in each patient age category. In gen-
eral, the data for all patients showed that the chance of
having an HLA-matching sibling was 60% in our
center. The actual probability of having a matching
sibling was 43.4% in group 1, 61.5% in group
2, 53.3% in group 3, and 68.6% in group 4. Thus,
the patients in group 1 (aged 0-5 years) had the lowest
chance of finding a matching sibling. Moreover, the
predicted probability of finding a matching sibling
for the 4 age groups was 54.0% in group 1, 64.5% in
group 2, 69.3% in group 3, and 73.4% in group 4.
The actual probability of finding a matching sibling
was lower than the predicted one across the 4 age
groups.
Using the multivariate logistic regression model
to identify the predictors of finding a matching do-
nor, as shown in Table 4, we found that the only sta-
tistically significant predictor among age, sex, and
number of siblings was number of siblings, with a rel-
ative risk (RR) of 1.28 (95% confidence interval
[CI]5 1.16-1.43; P # .0001). The other 2 variables
were not statistically significantly associated with
the chance of finding a matching sibling.DISCUSSION
The largest country on the Arabian Peninsula,
Saudi Arabia is known for its large families and high
rate of consanguineous marriage. King Abdul Aziz
Medical City, one of the largest hospitals in Riyadh,
Saudi Arabia, receives numerous blood samples from
patients requiring HCT for HLA typing every year.
In this study, we investigated the chance of finding
an HLA-matching sibling for each patient requiring
HCT at our center. We found that overall, 60% of
our patients had an identical matching sibling, with pa-
tients aged.20 years having the highest chance (68%)
and those aged 0-5 years having the lowest chance
(43%) of finding a matching sibling.We also examined
the different variables for a possible association with
the increased chance of finding an HLA-matching sib-
ling in older patients. We found that age and sex are
not associated, but the number of siblings is signifi-
cantly associated with the increased chance of finding
a matching sibling. Theoretically, this would explain
our results, because older people commonly have
more siblings than younger people whose families
are still growing.We estimated that for each additional
sibling in a family, there is 28% increase in the chance
Table 3. Number and Percentage of Patients with HLA-Matched Siblings and the Observed and Predicted Probabilities of Finding
a Matched Sibling
Potential Donors by Age Group, Years
0-5 6-10 11-20 >20 All Patients
Number of matching
siblings, n (%)
Zero 30 (56.6) 30 (38.5) 49 (46.7) 58 (31.4) 167 (39.7)
One 15 (28.3) 30 (38.5) 36 (34.3) 77 (41.6) 158 (37.5)
Two 6 (11.3) 12 (15.4) 13 (12.4) 41 (22.2) 72 (17.1)
Three 2 (3.8) 4 (5.1) 5 (4.8) 7 (3.8) 18 (4.3)
Four 0 (0) 0 (0) 1 (1.0) 1 (0.5) 2 (0.5)
Five 0 (0) 2 (2.6) 1 (1.0) 1 (0.5) 4 (1.0)
Probability of finding
a match, %
Actual 43.4 61.5 53.3 68.6 60.3
Predicted 54.0 64.5 69.3 73.4 68.4
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ent from what would be expected by chance (25%).
Consanguineousmarriage did not play a significant
role in finding a matching sibling. Although 16% of
our tested parents shared a haplotype, no significant
difference in the chance of finding a matching sibling
was seen between families with parents sharing a haplo-
type and those with parents not sharing a haplotype
(data not shown).
Although Saudi Arabia has a large number of pa-
tients requiring HCT and organ transplantation each
year, it lacks a local donor registry. The chance of find-
ing a matchedHCT donor for a Saudi patient from the
international unrelated stem cell registries is only 2%-
5% (M. Al-Awwami, King Faisal Specialist Hospital
and Research Center, personal communication, April,
2009). This is mainly because of the difference in anti-
gen frequency; for example, comparing the the Saudi
population with a European Caucasoid population re-
vealed considerable differences inHLA-A1, -A3, -A23,
-A28, -A30, -B50, -B51, -B53, -B58, -B41, and -B49
[8]. Based on the patient donor list in our center, pa-
tients without a matching sibling have an only 1 in
10 chance of finding a matching unrelated donor
(MUD). This is based on a limited number of donors.
Our results are based on the number of donors tested
in our center, which does not reflect the true number
of siblings, suggesting an even higher chance of finding
a matching sibling.
In conclusion, our Saudi patients’ chance of find-
ing an HLA-matching sibling appears high. This is
mainly because Saudi families are large, and the
more siblings, the greater the chance of finding a fullyTable 4. Multivariate Logistic Regression Model to Identify





Age 1.01 0.99-1.02 .4
Sex 0.91 0.61-1.38 .7
Number of siblings 1.28 1.16-1.43 < .0001identical matching sibling. But, despite the fact that
Saudi patients have a very good chance of finding
a matching sibling, a significant percentage still cannot
find a donor. Of even greater concern are our younger
children, who have a much lower chance of finding
a matching sibling because of their smaller number
of siblings. These young children usually suffer from
life-threatening diseases that can be cured only by
HCT and thus must consider unrelated donors. Our
data suggest that even in a country with relatively large
families, it is still essential to consider alternative do-
nor strategies such as adult unrelated donors, unre-
lated umbilical cord blood units, and haploidentical
donors.
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